Mitochondrial RNA polymerase (MtRPOL) inhibitors constitute a class of compounds that display a significant impact on the transcriptional processes occurring within the mitochondria. The mitochondrion, often referred to as the powerhouse of the cell, plays a pivotal role in energy production through oxidative phosphorylation. This intricate process is contingent on the harmonious interplay of various enzymatic activities, including mitochondrial RNA polymerases. These enzymes are instrumental in transcribing the genetic information encoded in the mitochondrial DNA (mtDNA) into RNA molecules, which subsequently guide the synthesis of essential proteins involved in energy production and maintenance of mitochondrial function. MtRPOL inhibitors are characterized by their ability to impede the progression of mitochondrial transcription by selectively targeting the mitochondrial RNA polymerases. By doing so, these inhibitors can modulate the intricate network of gene expression within the mitochondria.
They often exert their effects through binding to specific domains on the enzyme, thus hindering its binding to the mitochondrial DNA template and subsequently obstructing the elongation of RNA strands. This disruption in transcriptional activity leads to a downstream impact on mitochondrial protein synthesis, potentially affecting critical components of the oxidative phosphorylation pathway. The development and utilization of MtRPOL inhibitors have significantly contributed to our understanding of mitochondrial biology and the underlying molecular mechanisms governing energy production within the cell. These inhibitors serve as valuable tools in research aimed at dissecting the intricate pathways involved in mitochondrial gene expression. By selectively targeting and modulating mitochondrial RNA polymerase activity, researchers gain insights into the interplay between nuclear and mitochondrial genomes, as well as the nuanced regulatory mechanisms that dictate mitochondrial function. Such inhibitors have proven to be indispensable in unraveling the molecular intricacies of mitochondrial biology and its implications for cellular health and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aspirin | 50-78-2 | sc-202471 sc-202471A | 5 g 50 g | $20.00 $42.00 | 4 | |
Irreversible inhibitor of cyclooxygenase (COX) enzymes, preventing the conversion of arachidonic acid to prostaglandins, which are involved in inflammation and pain signaling. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
Inhibits the enzyme xanthine oxidase, involved in the conversion of purines to uric acid, thereby reducing uric acid production and preventing gout. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Proton pump inhibitor that irreversibly inhibits the H+/K+ ATPase enzyme in gastric parietal cells, decreasing stomach acid production and used for conditions related to excess stomach acid. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
Inhibits HMG-CoA reductase, a key enzyme in cholesterol biosynthesis, leading to reduced cholesterol production and lower levels of LDL (low-density lipoprotein) cholesterol. | ||||||